Menu

Symposium Agenda

TIMESESSIONDESCRIPTION
8:00 AM – 9:00 AMNetworking & Registration
8:00 AM – 9:00 AMBreakfast
9:00 AM – 9:15 AMOpening Remarks
9:15 AM – 10:00 AMTargeting 2030: Market DynamicsThe healthcare delivery landscape is evolving rapidly, compelled by simultaneous forces on multiple fronts. Provider networks are consolidating and facing economic pressures from strained legacy operating models and a rising tide of more financially motivated ownership. Demand continues to escalate as the population grows more numerous, older, and less active. Pervasiveness of technology and data are reshaping the expectations of patients, providers, and payors. Join us as we discuss how these dynamics converge, their potential implications for device manufacturers, and what opportunities and challenges we can expect in 2030.
10:00 AM – 10:15 AMNetworking Break
10:15 AM – 11:00 AMEngaging in 2030: Centers of GravityThe “med” and “tech” nucleus of our industry is advertised up front. But clinical and engineering chops alone are profoundly insufficient to guarantee product success. New stakeholders have entered the arena and gained clout. Balances of power have shifted. Who will drive purchasing decisions in 2030 and what motivates and constrains them? How do we design and build products that are in step with modern consumer preferences and social priorities, as expressed both through the market and via regulations? Our panelists examine the changing face of market demand and the nature of products best positioned to meet it.
11:00 AM – 11:15 AMNetworking Break
11:15 AM – 12:00 PMPlanning for 2030: Lessons from the Last Five YearsThe last five years have been tumultuous and unrelenting in the medtech industry. They’ve also been profoundly instructive in the need for contingency strategy, and its evolution and use to ensure business continuity. Setting our organizations up for predictable operation and protecting our customers from supply interruptions are core to what we do. New challenges are coming. With borders less open today than they have been, how do we weigh and mitigate geopolitical risk while benefiting from the global supply chain? How do we address the need for continual supply of skilled work when the labor market becomes volatile or irregular? How do we fortify digital and physical operations together? We invite you to expect the unexpected with us, as our expert panel looks at organizational resilience and adaptability.
12:00 PM – 1:00 PMLunch Buffet & Networking
1:00 PM – 1:15 PMTransition Time
1:15 PM – 2:00 PMBreakout Session 1 with Three Concurrent Tracks
1A: Cardiac HealthTalking Tech
A conversation with experts sharing insights from the frontiers of the cardiovascular market. This panel of cardiac innovators will discuss what trends we are seeing in product and clinical successes driving medtech forward.
1B: Musculoskeletal HealthTalking Tech
A conversation with experts sharing insights from the frontiers of the musculoskeletal market. This panel of MSK innovators will discuss what trends we are seeing in product and clinical successes driving medtech forward.
1C: DiabetesTalking Tech
A conversation with experts sharing insights from the frontiers of the diabetes market. This panel of diabetes innovators will discuss what trends we are seeing in product and clinical successes driving medtech forward.
2:00 PM – 2:15 PMNetworking Break
2:15 PM – 3:00 PMBreakout Session 2 with Three Concurrent Tracks
2A: Cardiac HealthFocus: The Narrow and the Broad
When entering a new product market, time and financial resources are at a premium. It’s imperative that a company be laser-focused in getting first product into the market to validate, de-risk, gain experience, and build credibility — even if the launch product and its indications only address a small portion of the true technical and clinical potential. How does a successful company establish near-term focus while seeing and setting up for the bigger picture? What are the team culture and management dynamics that underlie this? This conversation will feature the perspective of both early stage and commercially successful companies as they discuss an indispensable pattern in cardiac care and medical devices more broadly.
2B: Musculoskeletal HealthThe Great Migration
Few specialties have as many elective procedures as MSK; and more important than ever is the environment in which these elective procedures are being performed. As we contemplate a future in which patients might select a hip replacement by make, model, and price as they would a consumer appliance or car, the design and orientation of products necessarily morphs. How does a shift from surgeon focus to patient focus impact our product thinking? What role does pricing play? In what markets should we expect more realization, and how does this shape our approaches?
2C: DiabetesTechnology in Access to Individualized Care
Diabetes care is a life-long, multi-faceted proposition in which one size does not fit all. For people living with diabetes, access to resources best suited to their care needs can be the difference between positive health outcomes and negative ones, with the latter imposing substantial financial costs on payors and society at large. Two key dimensions to bridging this divide are space and time: well suited care resources exist; but are they available where individuals can access them when they need them? Technology can address this; and our journey is only beginning. Join our panel as we discuss the future of technology in enhancing access to maximally effective, individually tailored care.
3:00 PM – 3:15 PMNetworking Break
3:15 PM – 4:00 PMBreakout Session 3 with Three Concurrent Tracks
3A: Cardiac HealthTales from the Other side: A Fireside Chat
The big pivot meets with big success: it’s the stuff of legend…and when the curtain is peeled back, lessons hard learned. Sometimes overnight success takes a while. Join us for an in-depth conversation with a leader in the cardiac space as we dig into lessons learned from a hard earned success.
3B: Musculoskeletal HealthTaking on Policy “What Ifs?”
Regardless of politics, there is policy. And when policy changes, the opportunity landscape changes. Business approaches and product positioning that were recently strong may encounter new obstacles; and ones that were previously nonviable may become open doors. In order to be successful, companies must evaluate strategy in context. Our industry experts will lay out various scenarios, rooted in potential policy updates, and discuss how companies may capitalize on each.
3C: DiabetesDrug Delivery: A Gold Standard?
When it comes to drug delivery, it would appear that the diabetes sector of the medtech industry has it “figured out.” Wearable, minimal, ergonomic devices featuring a strong user-focus have achieved tremendous commercial success for both continuous administration of medication and diagnostic monitoring of diabetes. Relative outsiders in the drug creation space have noticed. What are the characteristics upon which this success is predicated? Are these attributes portable or replicable to medical uses outside of diabetes? This panel will examine the factors for the sector’s success, lessons learned, and how we might apply these in other clinical areas.
4:00 PMSymposium Concludes

GALA Agenda

TIMESESSION
6:00 PMRegistration for the Gala Opens, Cocktail Reception
7:00 PMDinner & Program
9:00 PMDessert Reception
10:30 PMGala Concludes